Company: PGEN
Filing Date: 2025-04-28
Form Type: 10-K/A
Source: 0001356090-25-000011
Chunk: 30

Company: PRECIGEN, INC.
Filing Date: 2025-04-28
Form: 10-K/A
Chunk 30
---
ATE)    |     | Gossamer Bio (GOSS)            |     | Gritstone bio (GRTS)        |     | IDEAYA Biosciences (IDYA)    |
| ImmunityBio (IBRX)               |     | Inovio Parmaceuticals (INO) |     | Iovance Biotherapeutics (IOVA) |     | Lyell Immunopharma (LYEL)   |     | PDS Biotechnology (PDSB)     |
| Poseida Therapeutics (PSTX)      |     | REGENXBIO (RGNX)            |     | Sana Biotechnology (SANA)      |     | Sangamo Therapeutics (SGMO) |     | VIR Biotechnology (VIR)      |
| Xencor (XNCR)                    |     |                             |     |                                |     |                             |     |                              |

<div align='center'>17</div>

At the time the peer group for 2024 was proposed to the Compensation Committee, the peer group had the following median statistics:

| Measure               |     | 50th Percentile |     | Precigen’s Position              |
| Market Capitalization |     | $512 million    |     | $366.0 million (46th percentile) |
| Revenues              |     | $14.3 million   |     | $22.1million (51th percentile)   |
| Annualized 3-Year TSR |     | -40%            |     | -32% (65th percentile)           |

In preparation for making 2024 compensation decisions, the Compensation Committee reviewed the existing compensation peer group in consultation with its independent compensation consultant for continued financial and business fit and made the following updates to the prior year’s peer group:

The following companies were removed from the 2023 peer group:

• NGM Biopharmaceutics (NGM)

• Precision Biosciences (DTIL)

• Revolution Medicines (RVMD)

• Sorrento Therapeutics (SRNE)

• TCR2 Therapeutics (TCRR)

• Vaccitech (VACC)

• VBI Vaccines (VBIV)

The following companies were added to the 2024 peer group:

• Adaptimmune Therapeutics (ADAP)

• Allovir (ALVR)

• Gossamer Bio (GOSS)

• Immunity Bio (IBRX)

• PDS Biotechnology (PDSB)

• Sangamo Therapeutics (SG